Krishna Yeshwant, Director, 10% Owner at Verve Therapeutics, Inc. (VERV), sold 144,856 shares at $31.12 ($3.0M) on 2022-11-04, disclosed to the SEC on 2022-11-08.
Open-market sale of $3.0M VERV by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 48,583 | $0 | 0.0% |
| 2 | $31.12 | 47,690 | $1.5M | 49.5% |
| 3 | $31.12 | 47,690 | $1.5M | 49.5% |
| 4 | $31.99 | 650 | $21K | 0.7% |
| 5 | $32.90 | 243 | $8K | 0.3% |
| Total | $20.69 avg | 144,856 |
| $3.0M |
| 100% |
| Filing → |
| VERV | SELL | 2022-11-02 | $6.5M | — | Filing → |
| FMI | SELL | 2017-08-10 | $192K | — | Filing → |
| FMI | SELL | 2017-08-08 | $1.3M | — | Filing → |